{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:09:48Z","timestamp":1790154588545,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11310-w","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:22:57Z","timestamp":1753100577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The contribution of TB rapid diagnostic testing in reducing TB-related mortality in Sub-Saharan Africa- in both Person-Living with HIV and HIV-Negative populations: A 9-year quantitative retrospective analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6050-4576","authenticated-orcid":false,"given":"Fru McWright","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri Claude","family":"Moungui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Agweh","family":"Musaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand Hugo","family":"Mbatchou-Ngahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"11310_CR1","unstructured":"Global Tuberculosis Report. 2024. 1st ed. Geneva: World Health Organization; 2024. 1 p."},{"key":"11310_CR2","unstructured":"global-tb-report. -2024_factsheet [Internet]. [cited 2025 Mar 4]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/global-tuberculosis-report-2024\/global-tb-report-2024_factsheet.pdf?sfvrsn=fee1c310_4&download=true"},{"key":"11310_CR3","unstructured":"WHO-HTM-TB. -2015.19-eng [Internet]. [cited 2025 Mar 4]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/331326\/WHO-HTM-TB-2015.19-eng.pdf?sequence=1"},{"key":"11310_CR4","unstructured":"political-declaration-un. -general-assembly-tb-tuberculosis77cd7a27-7e8d-4fbb-9729-a5dbd505798f [Internet]. [cited 2025 Mar 4]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/tuberculosis\/political-declaration-un-general-assembly-tb-tuberculosis77cd7a27-7e8d-4fbb-9729-a5dbd505798f.pdf?sfvrsn=4f4090dc_1&download=true"},{"key":"11310_CR5","unstructured":"who-ucn-tb. -2023.3 [Internet]. [cited 2025 Feb 1]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/un-high-level-meeting-on-tb\/who-ucn-tb-2023.3.pdf?sfvrsn=e7c6c3b3_5&download=true"},{"key":"11310_CR6","unstructured":"WHO Operational Handbook on Tuberculosis. Module 3: Diagnosis - Rapid Diagnostics for Tuberculosis Detection. 3rd Edition. 3rd ed. Geneva: World Health Organization. 2024. 1 p."},{"key":"11310_CR7","doi-asserted-by":"publisher","unstructured":"Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S et al. Impact of the diagnostic test Xpert MTB\/RIF on patient outcomes for tuberculosis - Haraka, F\u2013\u20092021| Cochrane Library. [cited 2025 Feb 1]; Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/https:\/\/doi.org\/10.1002\/14651858.CD012972.pub2\/full","DOI":"10.1002\/14651858.CD012972.pub2\/full"},{"issue":"10024","key":"11310_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","volume":"387","author":"JG Peter","year":"2016","unstructured":"Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, et al. Effect on mortality of point-of-care, urine-based Lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187\u201397.","journal-title":"Lancet"},{"issue":"1","key":"11310_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1186\/s12879-022-07855-9","volume":"22","author":"JH Lee","year":"2022","unstructured":"Lee JH, Garg T, Lee J, McGrath S, Rosman L, Schumacher SG, et al. Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2022;22(1):940.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"11310_CR10","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1016\/S2214-109X(23)00135-3","volume":"11","author":"T Broger","year":"2023","unstructured":"Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc FX, et al. Diagnostic yield of urine Lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health. 2023;11(6):e903\u201316.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"11310_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/1471-2334-14-477","volume":"14","author":"CM Denkinger","year":"2014","unstructured":"Denkinger CM, Kampmann B, Ahmed S, Dowdy DW. Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis. BMC Infect Dis. 2014;14(1):477.","journal-title":"BMC Infect Dis"},{"issue":"10144","key":"11310_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","volume":"392","author":"A Gupta-Wright","year":"2018","unstructured":"Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292\u2013301.","journal-title":"Lancet"},{"issue":"10","key":"11310_CR13","first-page":"CD011420","volume":"2019","author":"S Bjerrum","year":"2019","unstructured":"Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, et al. Lateral flow urine Lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019;2019(10):CD011420.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"11310_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/INF.0000000000001563","volume":"36","author":"E Walters","year":"2017","unstructured":"Walters E, van der Zalm MM, Palmer M, Bosch C, Demers AM, Draper HR, et al. Xpert MTB\/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease. Pediatr Infect Dis J. 2017;36(9):837\u201343.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"11310_CR15","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1128\/JCM.00330-13","volume":"51","author":"NA Feasey","year":"2013","unstructured":"Feasey NA, Banada PP, Howson W, Sloan DJ, Mdolo A, Boehme C, et al. Evaluation of Xpert MTB\/RIF for detection of Tuberculosis from blood samples of HIV-Infected adults confirms Mycobacterium tuberculosis bacteremia as an Indicator of poor prognosis. J Clin Microbiol. 2013;51(7):2311\u20136.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"11310_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12962-024-00544-1","volume":"22","author":"LF Assebe","year":"2024","unstructured":"Assebe LF, Erena AK, Fikadu L, Alemu B, Baruda YS, Jiao B. Cost-effectiveness of TB diagnostic technologies in ethiopia: a modelling study. Cost Eff Resour Alloc. 2024;22(1):43.","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"11310_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1741-7015-11-231","volume":"11","author":"SD Lawn","year":"2013","unstructured":"Lawn SD, Kerkhoff AD, Vogt M, Wood R. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Med. 2013;11(1):231.","journal-title":"BMC Med"},{"issue":"1","key":"11310_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12879-018-3656-x","volume":"19","author":"M Lisboa","year":"2019","unstructured":"Lisboa M, Fronteira I, Colove E, Nhamonga M, Martins M. Time delay and associated mortality from negative smear to positive Xpert MTB\/RIF test among TB\/HIV patients: a retrospective study. BMC Infect Dis. 2019;19(1):18.","journal-title":"BMC Infect Dis"},{"key":"11310_CR19","unstructured":"Variation in the observed effect of Xpert\u2026 Wellcome Open Research [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/wellcomeopenresearch.org\/articles\/4-173\/v2."},{"key":"11310_CR20","unstructured":"2.2\u00a0TB mortality [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2021\/disease-burden\/mortality"},{"issue":"3","key":"11310_CR21","doi-asserted-by":"publisher","first-page":"1900312","DOI":"10.1183\/13993003.00312-2019","volume":"54","author":"AL Garcia-Basteiro","year":"2019","unstructured":"Garcia-Basteiro AL, Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, et al. Unmasking the hidden tuberculosis mortality burden in a large post mortem study in Maputo central hospital, Mozambique. Eur Respir J. 2019;54(3):1900312.","journal-title":"Eur Respir J"},{"issue":"5","key":"11310_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S1473-3099(15)70058-7","volume":"15","author":"M Bates","year":"2015","unstructured":"Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015;15(5):544\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"11310_CR23","doi-asserted-by":"publisher","first-page":"e112017","DOI":"10.1371\/journal.pone.0112017","volume":"9","author":"A Odone","year":"2014","unstructured":"Odone A, Amadasi S, White RG, Cohen T, Grant AD, Houben RMGJ. The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: A systematic review and Meta-Analysis. PLoS ONE. 2014;9(11):e112017.","journal-title":"PLoS ONE"},{"key":"11310_CR24","unstructured":"2.4 Prevention of TB.| TB Knowledge Sharing [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/tbksp.who.int\/en\/node\/2810?utm_source=chatgpt.com"},{"issue":"1","key":"11310_CR25","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2352-3018(20)30299-X","volume":"8","author":"JM Ross","year":"2021","unstructured":"Ross JM, Badje A, Rangaka MX, Walker AS, Shapiro AE, Thomas KK, et al. Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. Lancet HIV. 2021;8(1):e8\u201315.","journal-title":"Lancet HIV"},{"issue":"5","key":"11310_CR26","doi-asserted-by":"publisher","first-page":"e0266285","DOI":"10.1371\/journal.pone.0266285","volume":"17","author":"A Kazibwe","year":"2022","unstructured":"Kazibwe A, Oryokot B, Mugenyi L, Kagimu D, Oluka AI, Kato D, et al. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated Isoniazid preventive therapy: A multi-center retrospective cohort study. PLoS ONE. 2022;17(5):e0266285.","journal-title":"PLoS ONE"},{"issue":"6","key":"11310_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4103\/ijmr.IJMR_1582_18","volume":"152","author":"C Padmapriyadarsini","year":"2020","unstructured":"Padmapriyadarsini C, Sekar L, Reddy D, Chitra A, Poornagangadevi N, Selvaraj M, et al. Effectiveness of Isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting. Indian J Med Res. 2020;152(6):648\u201355.","journal-title":"Indian J Med Res"},{"issue":"4","key":"11310_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.35772\/ghm.2023.01013","volume":"5","author":"AK Ghosh","year":"2023","unstructured":"Ghosh AK. Four decades of continuing innovations in the development of antiretroviral therapy for HIV\/AIDS: progress to date and future challenges. Glob Health Med. 2023;5(4):194\u20138.","journal-title":"Glob Health Med"},{"issue":"1","key":"11310_CR29","doi-asserted-by":"publisher","first-page":"e28320","DOI":"10.1002\/jmv.28320","volume":"95","author":"AO Babatunde","year":"2023","unstructured":"Babatunde AO, Akin-Ajani OD, Abdullateef RO, Togunwa TO, Isah HO. Review of antiretroviral therapy coverage in 10 highest burden HIV countries in africa: 2015\u20132020. J Med Virol. 2023;95(1):e28320.","journal-title":"J Med Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11310-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:25:06Z","timestamp":1757262306000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11310"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11310-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6234923\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"929"}}